SteriPath Gen2 showing diverted contaminants

Steripath Logo

Eliminate blood culture contamination.

Introducing Steripath® Gen2– the vein-to-bottle, closed blood culture collection system that is clinically proven to virtually eliminate the preventable error of blood culture contamination and false-positive results for sepsis.

The Benefits

of virtually eliminating blood culture contamination with Steripath

Improve Patient Safety

• Reduce the risk of C. Diff & antibiotic-resistant infections by decreasing unecessary antibiotic usage

• Reduce the risk of HAC/HAIs due to unnecessarily extended length of stay

Drive Antibiotic Stewardship

Reduce broad-spectrum antibiotic use

Supports compliance with federal and state mandates to reduce inappropriate antibiotic usage

Reduce Hospital Costs

Avoid non-reimbursable costs for:

• Additional procedures, clinical coordination and length of stay

• Unnecessary antibiotics, HAI/HAC events

 

Enhance Quality Outcome Metrics

• Positively impact key CMS quality outcome metrics including reduced C. Diff. & HAI occurrences

• Reduce false reporting for CLABSIs by by virtually eliminating false-positive blood cultures

A Contaminated Culture

Blood cultures remain the gold standard for diagnosing sepsis– the leading cause of death and readmission in US hospitals. Even with best practices, between 35-50% of positive blood culture results are contaminated, resulting in false-positive diagnoses that place over one million lives at risk each year.

Even current best practices are susceptible to:

Diagnosing Sepsis Human Factors

Human Factors

Risk of contamination during assembly and preparation of supplies, and skin prep

Diagnosing Sepsis Skin Flora

Skin Flora

You can disinfect but not sterilize the skin; up to 20% of skin flora remains viable in the keratin layer of the skin even after skin prep

Diagnosing Sepsis Skin Plugs

Skin Plugs

 Skin plugs, when present, will always enter the culture specimen bottle and commonly will contain microorganisms

Technology & Features

Steripath Logo
PROPRIETARY

Initial Specimen Diversion Mechanism
diverts and sequesters the initial (potentially contaminated) specimen into the isolation chamber

PROPRIETARY

Specimen Isolation Chamber
ensures sequestered contaminants are isolated from the blood culture specimen

PROPRIETARY

User-Controlled Diversion
enables necessary adjustments for “hard stick” patients with low venous pressure through negative pressure

PROPRIETARY

Independent 2nd Sterile Blood Flow Path
allows only pure venous blood, without skin contaminants, to flow into culture bottles

Comes Preassembled & Sterile
to eliminate touch-point contamination

Steripath is available in multiple configurations

Users can collect blood cultures through peripheral sticks and initial IV starts.  It is also compatible with standard blood collection tubes and culture bottles made by BD, bioMerieux and certain Thermo Scientific products.

Available Extensions

21g Butterfly Needle
21g push button safety needle
23g Butterfly Needle
23g push button safety needle
Luer IV Extension Set
Luer IV Extension Set

Available Transfer Adapters

Thermo Scientific adaptor
Thermo Scientific adaptor
Smiths Adaptor
Smiths Adaptor
BD Adaptor
BD Adaptor
10mL Syringe
syringe (coming soon)
SteriPath Gen2 Syringe

Syringe Coming Soon

We’re with you, every step of the way

Our Clinical Partnership Includes:

• Pre-training and logistics including implementation planning meetings and online training

• Initial onsite implementation including train-the-trainer programs, sharing best practices, demonstrations, coaching, and training certifications

• Post-training resources including ongoing online training, onsite education, and retention modules

• Ongoing clinical support including tracking, reporting, compliance programs, root cause analysis, and clinical reviews

We Guarantee Your Results

With our proven technology, we guarantee you will achieve a sustained reduction in blood culture contamination of 50% or greater.

Optimize our partnership

For our most dedicated customers, our Blood Culture Integrity Partnership Program offers the greatest value and return.  Ask us how.

Steripath has been clinically proven to sustain a blood culture contamination rate as low as 0.2% and a reduction in false positives by up to 92%.